The NIH funds an initiative to assess the safety of CRISPR-like therapies in human tissues
A new model system offers clues
The Psychiatric Cell Mapping Initiative is led by researchers at Gladstone and UC San Francisco
Todd McDevitt becomes program director and co-chair of the executive committee
Gladstone scientists receive funding to develop new drugs to reduce tau levels in the brain
The ALS Association recognized Steven Finkbeiner’s pioneering work and urgent focus to bring effective treatments to patients with ALS.
Gladstone researcher is elected VP of the preeminent organization dedicated to stem cell research and treatments
Melanie Ott has been elected as a fellow of The American Academy of Microbiology, joining others with exemplary scientific achievement in microbial sciences.
The funded program will, for the first time, introduce gene editing and stem cell therapies in the search for a potential cure
The NINDS award provides longer-term support and increased flexibility to pursue innovative, high-risk research on neurological diseases.